Boston Scientific Corporation (VIE:BSXC)

Market Cap	80.87B -40.9%
Revenue (ttm)	17.10B +19.9%
Net Income	2.47B +56.4%
EPS	1.65 +55.2%
Shares Out	n/a
PE Ratio	32.76
Forward PE	18.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	567
Average Volume	668
Open	53.40
Previous Close	54.20
Day's Range	53.40 - 54.60
52-Week Range	53.40 - 94.80
Beta	n/a
RSI	26.01
Earnings Date	Apr 22, 2026

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatogra...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1979
• Employees: 59,000
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: BSXC

Financial Performance

In 2025, Boston Scientific's revenue was $20.07 billion, an increase of 19.87% compared to the previous year's $16.75 billion. Earnings were $2.90 billion, an increase of 56.40%.

Financial numbers in USD